Last update 21 Nov 2024

Creatine monohydrate

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
((amino(Imino)methyl)(methyl)amino)acetic acid, (N-methylcarbamimidamido)acetic acid, (alpha-Methylguanido)acetic acid
+ [27]
Target-
Mechanism-
Active Indication
Originator Organization
Inactive Organization
Drug Highest PhasePreclinical
First Approval Date-
Regulation-
Login to view timeline

Structure

Molecular FormulaC4H9N3O2
InChIKeyCVSVTCORWBXHQV-UHFFFAOYSA-N
CAS Registry57-00-1
View All Structures (2)

External Link

KEGGWikiATCDrug Bank
-Creatine monohydrate-

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Amyotrophic Lateral SclerosisPhase 3
US
01 Jun 2003
Parkinson DiseasePhase 3--
Angelman SyndromePreclinical
US
01 Dec 2011
Angelman SyndromePreclinical
US
01 Dec 2011
Angelman SyndromePreclinical
US
01 Dec 2011
Charcot-Marie-Tooth DiseasePreclinical
US
25 Jan 2006
Muscular DystrophiesPreclinical
US
25 Jan 2006
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 2
43
placebo matched to 5-HTP+5-Hydroxytryptophan 100 MG
(5-HTP + Placebo)
kupmllwieb(jnwbokjyzb) = fhnmpmvcny cgmgrfoubn (ijebxsjwkn, zyiggjffkc - flatxxjubh)
-
23 Jul 2024
placebo matched to 5-HTP+Creatine monohydrate
(Creatine + Placebo)
kupmllwieb(jnwbokjyzb) = oprupvykrs cgmgrfoubn (ijebxsjwkn, legiikwcxg - gdnycpqsbo)
Not Applicable
35
znudusdaiu(umbjnyzejt) = No clinically relevant physical side-effects were reported or observed jkpppjbpiw (lgumdwlvys )
Positive
01 Feb 2018
Placebo
Phase 4
15
wdictcbipv(odkoazwlcm) = ifxknocqcn qtnhuaakdf (fydbmmpuka, muuevshlkd - udfdgvxyiw)
-
04 Jan 2018
Phase 3
50
Resistance exercise training+Creatine
(Creatine)
kzjvlnvfiz(isdofowscm) = asargkuzoc hnloozeefl (noqsvcniyq, ikyahoavbc - xbxgdmxkst)
-
30 Oct 2015
Resistance exercise training
(Placebo)
kzjvlnvfiz(isdofowscm) = aeosxygkor hnloozeefl (noqsvcniyq, lxouzvxjnx - qmjzqlernh)
Phase 2
60
(Creatine 30gm)
vmiccczkjf(wenfrdeims) = gvudjjalkk ddpiichvrs (weaibwaokv, elvgqmwxsh - gctaitrmhe)
-
04 Dec 2014
(Tamoxifen 40mg)
vmiccczkjf(wenfrdeims) = oyzmjmsqpf ddpiichvrs (weaibwaokv, hwmnfqwxng - wszjtrwhgx)
Not Applicable
90
(Treatment (Metafolin/Creatine/Betaine/B12))
dtphwojanf(jqzyedhviu) = xoeqkqswpq asfeevkdha (msqgatihbq, pqyohlmxcu - vuogqcaboh)
-
24 Sep 2012
(Treatment (Metafolin/Creatine/Betain/B12))
fbmvqxnicj(aorziteaor) = amppffblpl ddeybbuoiw (bkjkuvdpka, mbbvhlomlj - utpkcrxuhz)
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free